Report Detail
Global Hydroxycarbamide Market Growth 2019-2024
- RnM3002169 |
- 22 February, 2019 |
- Global |
- 164 Pages |
- LPI(LP Information) |
- Pharma & Healthcare
Hydroxycarbamide, also known as hydroxyurea, is a medication used in sickle-cell disease, chronic myelogenous leukemia, cervical cancer, and polycythemia vera. In sickle-cell disease it decreases the number of attacks. It is taken by mouth.
Common side effects include bone marrow suppression, fevers, loss of appetite, psychiatric problems, shortness of breath, and headaches. There is also concern that it increases the risk of later cancers. Use during pregnancy is typically harmful to the baby. Hydroxycarbamide is in the antineoplastic family of medications. It is believed to work by blocking the making of DNA.
The classification of Hydroxycarbamide includes capsule and tablet, and the proportion of capsule in 2016 is about 63%, and the proportion is in decreasing trend from 2012 to 2016.
Hydroxycarbamide is widely used for sickle cell disease, cancer and other disease. The most proportion of Hydroxycarbamide is used for sickle cell disease, and the proportion in 2016 is 45%.
Asia Pacific is the largest supplier of Hydroxycarbamide, with a production market share nearly 59% in 2016.
Middle East and Africa is the largest consumption place, with a consumption market share nearly 36% in 2016. Following Middle East and Africa, Asia Pacific is the second largest consumption place with the consumption market share of 20%.
Market competition is not intense. Bristol Myers Squibb, Taj Pharma, Beijing Jialin Pharma, Qilu Pharmaceutical, Teva Pharma, Cipla, Zydus Cadila, United Biotech, Par Pharma, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
According to this study, over the next five years the Hydroxycarbamide market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Hydroxycarbamide business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Hydroxycarbamide market by product type, application, key manufacturers and key regions and countries.
This study considers the Hydroxycarbamide value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Capsule
Tablet
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Sickle Cell Disease
Cancer
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Bristol Myers Squibb
Taj Pharma
Beijing Jialin Pharma
Qilu Pharmaceutical
Teva Pharma
Cipla
Zydus Cadila
United Biotech
Par Pharma
Khandelwal Laboratories
Alkem (Cytomed)
Samarth Pharma
VHB Life Sciences
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Hydroxycarbamide consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Hydroxycarbamide market by identifying its various subsegments.
Focuses on the key global Hydroxycarbamide manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Hydroxycarbamide with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Hydroxycarbamide submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
2019-2024 Global Hydroxycarbamide Consumption Market Report
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Research Objectives
- 1.3 Years Considered
- 1.4 Market Research Methodology
- 1.5 Economic Indicators
- 1.6 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Hydroxycarbamide Consumption 2014-2024
- 2.1.2 Hydroxycarbamide Consumption CAGR by Region
- 2.2 Hydroxycarbamide Segment by Type
- 2.2.1 Capsule
- 2.2.2 Tablet
- 2.3 Hydroxycarbamide Consumption by Type
- 2.3.1 Global Hydroxycarbamide Consumption Market Share by Type (2014-2019)
- 2.3.2 Global Hydroxycarbamide Revenue and Market Share by Type (2014-2019)
- 2.3.3 Global Hydroxycarbamide Sale Price by Type (2014-2019)
- 2.4 Hydroxycarbamide Segment by Application
- 2.4.1 Sickle Cell Disease
- 2.4.2 Cancer
- 2.4.3 Other
- 2.5 Hydroxycarbamide Consumption by Application
- 2.5.1 Global Hydroxycarbamide Consumption Market Share by Application (2014-2019)
- 2.5.2 Global Hydroxycarbamide Value and Market Share by Application (2014-2019)
- 2.5.3 Global Hydroxycarbamide Sale Price by Application (2014-2019)
3 Global Hydroxycarbamide by Players
- 3.1 Global Hydroxycarbamide Sales Market Share by Players
- 3.1.1 Global Hydroxycarbamide Sales by Players (2017-2019)
- 3.1.2 Global Hydroxycarbamide Sales Market Share by Players (2017-2019)
- 3.2 Global Hydroxycarbamide Revenue Market Share by Players
- 3.2.1 Global Hydroxycarbamide Revenue by Players (2017-2019)
- 3.2.2 Global Hydroxycarbamide Revenue Market Share by Players (2017-2019)
- 3.3 Global Hydroxycarbamide Sale Price by Players
- 3.4 Global Hydroxycarbamide Manufacturing Base Distribution, Sales Area, Product Types by Players
- 3.4.1 Global Hydroxycarbamide Manufacturing Base Distribution and Sales Area by Players
- 3.4.2 Players Hydroxycarbamide Products Offered
- 3.5 Market Concentration Rate Analysis
- 3.5.1 Competition Landscape Analysis
- 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
- 3.6 New Products and Potential Entrants
- 3.7 Mergers & Acquisitions, Expansion
4 Hydroxycarbamide by Regions
- 4.1 Hydroxycarbamide by Regions
- 4.1.1 Global Hydroxycarbamide Consumption by Regions
- 4.1.2 Global Hydroxycarbamide Value by Regions
- 4.2 Americas Hydroxycarbamide Consumption Growth
- 4.3 APAC Hydroxycarbamide Consumption Growth
- 4.4 Europe Hydroxycarbamide Consumption Growth
- 4.5 Middle East & Africa Hydroxycarbamide Consumption Growth
5 Americas
- 5.1 Americas Hydroxycarbamide Consumption by Countries
- 5.1.1 Americas Hydroxycarbamide Consumption by Countries (2014-2019)
- 5.1.2 Americas Hydroxycarbamide Value by Countries (2014-2019)
- 5.2 Americas Hydroxycarbamide Consumption by Type
- 5.3 Americas Hydroxycarbamide Consumption by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Key Economic Indicators of Few Americas Countries
6 APAC
- 6.1 APAC Hydroxycarbamide Consumption by Countries
- 6.1.1 APAC Hydroxycarbamide Consumption by Countries (2014-2019)
- 6.1.2 APAC Hydroxycarbamide Value by Countries (2014-2019)
- 6.2 APAC Hydroxycarbamide Consumption by Type
- 6.3 APAC Hydroxycarbamide Consumption by Application
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 Key Economic Indicators of Few APAC Countries
7 Europe
- 7.1 Europe Hydroxycarbamide by Countries
- 7.1.1 Europe Hydroxycarbamide Consumption by Countries (2014-2019)
- 7.1.2 Europe Hydroxycarbamide Value by Countries (2014-2019)
- 7.2 Europe Hydroxycarbamide Consumption by Type
- 7.3 Europe Hydroxycarbamide Consumption by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 7.9 Spain
- 7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
- 8.1 Middle East & Africa Hydroxycarbamide by Countries
- 8.1.1 Middle East & Africa Hydroxycarbamide Consumption by Countries (2014-2019)
- 8.1.2 Middle East & Africa Hydroxycarbamide Value by Countries (2014-2019)
- 8.2 Middle East & Africa Hydroxycarbamide Consumption by Type
- 8.3 Middle East & Africa Hydroxycarbamide Consumption by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Marketing, Distributors and Customer
- 10.1 Sales Channel
- 10.1.1 Direct Channels
- 10.1.2 Indirect Channels
- 10.2 Hydroxycarbamide Distributors
- 10.3 Hydroxycarbamide Customer
11 Global Hydroxycarbamide Market Forecast
- 11.1 Global Hydroxycarbamide Consumption Forecast (2019-2024)
- 11.2 Global Hydroxycarbamide Forecast by Regions
- 11.2.1 Global Hydroxycarbamide Forecast by Regions (2019-2024)
- 11.2.2 Global Hydroxycarbamide Value Forecast by Regions (2019-2024)
- 11.2.3 Americas Consumption Forecast
- 11.2.4 APAC Consumption Forecast
- 11.2.5 Europe Consumption Forecast
- 11.2.6 Middle East & Africa Consumption Forecast
- 11.3 Americas Forecast by Countries
- 11.3.1 United States Market Forecast
- 11.3.2 Canada Market Forecast
- 11.3.3 Mexico Market Forecast
- 11.3.4 Brazil Market Forecast
- 11.4 APAC Forecast by Countries
- 11.4.1 China Market Forecast
- 11.4.2 Japan Market Forecast
- 11.4.3 Korea Market Forecast
- 11.4.4 Southeast Asia Market Forecast
- 11.4.5 India Market Forecast
- 11.4.6 Australia Market Forecast
- 11.5 Europe Forecast by Countries
- 11.5.1 Germany Market Forecast
- 11.5.2 France Market Forecast
- 11.5.3 UK Market Forecast
- 11.5.4 Italy Market Forecast
- 11.5.5 Russia Market Forecast
- 11.5.6 Spain Market Forecast
- 11.6 Middle East & Africa Forecast by Countries
- 11.6.1 Egypt Market Forecast
- 11.6.2 South Africa Market Forecast
- 11.6.3 Israel Market Forecast
- 11.6.4 Turkey Market Forecast
- 11.6.5 GCC Countries Market Forecast
- 11.7 Global Hydroxycarbamide Forecast by Type
- 11.8 Global Hydroxycarbamide Forecast by Application
12 Key Players Analysis
- 12.1 Bristol Myers Squibb
- 12.1.1 Company Details
- 12.1.2 Hydroxycarbamide Product Offered
- 12.1.3 Bristol Myers Squibb Hydroxycarbamide Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.1.4 Main Business Overview
- 12.1.5 Bristol Myers Squibb News
- 12.2 Taj Pharma
- 12.2.1 Company Details
- 12.2.2 Hydroxycarbamide Product Offered
- 12.2.3 Taj Pharma Hydroxycarbamide Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.2.4 Main Business Overview
- 12.2.5 Taj Pharma News
- 12.3 Beijing Jialin Pharma
- 12.3.1 Company Details
- 12.3.2 Hydroxycarbamide Product Offered
- 12.3.3 Beijing Jialin Pharma Hydroxycarbamide Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.3.4 Main Business Overview
- 12.3.5 Beijing Jialin Pharma News
- 12.4 Qilu Pharmaceutical
- 12.4.1 Company Details
- 12.4.2 Hydroxycarbamide Product Offered
- 12.4.3 Qilu Pharmaceutical Hydroxycarbamide Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.4.4 Main Business Overview
- 12.4.5 Qilu Pharmaceutical News
- 12.5 Teva Pharma
- 12.5.1 Company Details
- 12.5.2 Hydroxycarbamide Product Offered
- 12.5.3 Teva Pharma Hydroxycarbamide Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.5.4 Main Business Overview
- 12.5.5 Teva Pharma News
- 12.6 Cipla
- 12.6.1 Company Details
- 12.6.2 Hydroxycarbamide Product Offered
- 12.6.3 Cipla Hydroxycarbamide Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.6.4 Main Business Overview
- 12.6.5 Cipla News
- 12.7 Zydus Cadila
- 12.7.1 Company Details
- 12.7.2 Hydroxycarbamide Product Offered
- 12.7.3 Zydus Cadila Hydroxycarbamide Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.7.4 Main Business Overview
- 12.7.5 Zydus Cadila News
- 12.8 United Biotech
- 12.8.1 Company Details
- 12.8.2 Hydroxycarbamide Product Offered
- 12.8.3 United Biotech Hydroxycarbamide Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.8.4 Main Business Overview
- 12.8.5 United Biotech News
- 12.9 Par Pharma
- 12.9.1 Company Details
- 12.9.2 Hydroxycarbamide Product Offered
- 12.9.3 Par Pharma Hydroxycarbamide Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.9.4 Main Business Overview
- 12.9.5 Par Pharma News
- 12.10 Khandelwal Laboratories
- 12.10.1 Company Details
- 12.10.2 Hydroxycarbamide Product Offered
- 12.10.3 Khandelwal Laboratories Hydroxycarbamide Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.10.4 Main Business Overview
- 12.10.5 Khandelwal Laboratories News
- 12.11 Alkem (Cytomed)
- 12.12 Samarth Pharma
- 12.13 VHB Life Sciences
13 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Hydroxycarbamide . Industry analysis & Market Report on Hydroxycarbamide is a syndicated market report, published as Global Hydroxycarbamide Market Growth 2019-2024. It is complete Research Study and Industry Analysis of Hydroxycarbamide market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
